Case Series of Myocarditis Following mRNA COVID Vaccine Compared to Pediatric Multisystem Inflammatory Syndrome: Multicenter Retrospective Study
Authors:
- Yonatan Butbul AvielYAYonatan Butbul Aviel
- Philip J. HashkesPHPhilip J. Hashkes
- Yotam DizitzerYDYotam Dizitzer
- Kanteman InbarKIKanteman Inbar
- Yackov BerkunYBYackov Berkun
- Eli M. EisensteinEEEli M. Eisenstein
- Mohamad Hamad SaiedMSMohamad Hamad Saied
- Ofra GoldzweigOGOfra Goldzweig
- Merav Heshin-BekensteinMHMerav Heshin-Bekenstein
- Eduard LingELEduard Ling
- Michal FeldonMFMichal Feldon
- Rotem TalRTRotem Tal
Open Access
Abstract
Introduction: Since the development of COVID-19 vaccines, more than 4.8 billion people have been immunized worldwide. Soon after vaccinations were initiated, reports on cases of myocarditis following the second vaccine dose emerged. This study aimed to report our experience with adolescent and young adults who developed post-COVID-19 vaccine myocarditis and to compare these patients to a cohort of patients who acquired pediatric inflammatory multisystem syndrome (PIMS/PIMS-TS) post-COVID-19 infection. Methods: We collected reported cases of patients who developed myocarditis following COVID-19 vaccination (Pfizer mRNA BNT162b2) from all pediatric rheumatology centers in Israel and compared them to a cohort of patients with PIMS. Results: Nine patients with post-vaccination myocarditis were identified and compared to 78 patients diagnosed with PIMS. All patients with post-vaccination myocarditis were males who developed symptoms following their second dose of the vaccine. Patients with post-vaccination myocarditis had a shorter duration of stay in the hospital (mean 4.4 ± 1.9 vs. 8.7 ± 4.7 days) and less myocardial dysfunction (11.1% vs. 61.5%), and all had excellent outcomes as compared to the chronic changes among 9.2% of the patients with PIMS. Conclusion: The clinical course of vaccine-associated myocarditis appears favorable, with resolution of the symptoms in all the patients in our cohort.Keywords
This publication has 19 references indexed in Scilit:
- BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Mass Vaccination SettingNew England Journal of Medicine, 2021
- Multisystem Inflammatory Syndrome in Children: An International SurveyPediatrics, 2021
- COVID‐19 and multisystem inflammatory syndrome in children: A systematic review and meta‐analysisPediatric Pulmonology, 2021
- Type I interferonopathies with novel compound heterozygous TREX1 mutations in two siblings with different symptoms responded to tofacitinibPediatric Rheumatology, 2021
- Distinctive Features of Kawasaki Disease Following SARS-CoV-2 Infection: a Controlled Study in Paris, FranceJournal of Clinical Immunology, 2021
- Safety and Efficacy of the BNT162b2 mRNA Covid-19 VaccineNew England Journal of Medicine, 2020
- Safety and Immunogenicity of Two RNA-Based Covid-19 Vaccine CandidatesNew England Journal of Medicine, 2020
- Hyperinflammatory shock in children during COVID-19 pandemicThe Lancet, 2020
- National Trends, Gender, Management, and Outcomes of Patients Hospitalized for MyocarditisThe American Journal of Cardiology, 2019
- Myocarditis and pericarditis after immunization: Gaining insights through the Vaccine Adverse Event Reporting SystemInternational Journal of Cardiology, 2018